DUOX2激活驱动细菌转位和亚临床炎症在IBD相关的失生症
Hajar Hazime1,2, Gloria Michelle Ducasa1, Ana M Santander1
1Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA.
Gut
|April 29, 2025
概括
在肠道中增加的双氧化酶2 (DUOX2) 信号增加了肠道的透性和炎症,改变了微生物群. 丁酸盐和HDAC抑制剂逆转了这些效应,表明DUOX2是炎症性肠道疾病 (IBD) 的潜在治疗标.
科学领域:
- 胃肠道学和免疫学
- 微生物组研究 微生物组研究
- 分子生物学分子生物学
背景情况:
- 炎症性肠道疾病 (IBD) 与肠道失生症和增加肠道透性有关.
- 双氧化酶2 (DUOX2) 在IBD患者中被上调,但其具体作用尚不清楚.
研究的目的:
- 研究表皮DUOX2活动对IBD宿主和肠道微生物群的功能影响.
主要方法:
- 使用了具有改变DUOX2表达 (过度激活/失活) 和野生类型控制的小鼠模型.
- 评估了IBD或健康微生物群殖民的无菌小鼠的肠道透性,细菌转移和炎症.
- 采用RNA测序,便代谢学以及对结肠杆菌,活检和患者血清的研究来分析宿主-微生物相互作用.
主要成果:
- 皮质DUOX2过度激活增加了小鼠的肠道透性,细菌转位和亚临床炎症.
- 在IBD患者中,DUOX2表达与血松素升高和ZO-1表达降低相关.
- IBD微生物群加剧了DUOX2活性,导致炎症和屏障缺陷,同时改变了微生物群并减少了像丁酸盐这样的有益代谢物.
结论:
- 增加的DUOX2信号传递有助于上皮屏障功能障碍,微生物组失调和IBD中的炎症.
- 丁酸盐和胰岛素脱乙酶 (HDAC) 抑制剂有效地逆转了DUOX2介导的作用.
- DUOX2 是治疗炎症性肠道疾病的有前途的治疗标.
相关概念视频
Chronic Bowel Disorders: Introduction
300
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
300
Inflammatory Bowel Disease II: Crohn's Disease
124
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
124
Inflammatory Bowel Disease I: Ulcerative Colitis
93
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
93
Irritable Bowel Syndrome I: Introduction
201
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
201
Drugs for Treatment of Diarrhea-Predominant IBS
117
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
117
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
223
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
223


